Most Cancers Can Be Successfully Treated If Detected Early.

Early detection is one of cancer's greatest weaknesses. Detection of cancer in the early stage increases the likelihood of successful treatment since the tumor is typically smaller in size and has not spread to other parts of the body. Early detection can result in better outcomes and increased survival rates, as compared to discovering cancer later on, when it has advanced and is more challenging to treat.

Who We Are

PredOmix is an innovation driven health tech company where we aim to pioneer cancer detection through our breakthrough multi-cancer early detection test.

Our company is dedicated to developing and innovative technologies that enable early detection and diagnosis of a range of cancers, helping to improve outcomes and save lives.

 

 

Discover a new non-invasive cancer detection test using metabolomics and deep learning technologies.

 

PredOmix At A Glimpse

With a team of experienced and passionately driven scientists, coupled with extensive subject matter expertise, we are confident in our ability to successfully transform early cancer detection and improve the quality of lives for patients and their families.

Dr. Kanury V S Rao

Co-Founder & Chief Scientific Officer (CSO)

Dr. Kanury V S Rao

Co-Founder & Chief Scientific Officer (CSO)

Dr. Kanury V S Rao

Co-Founder & Chief Scientific Officer (CSO)

Dr. Kanury V S Rao

Co-Founder & Chief Scientific Officer (CSO)

Dr. Kanury V S Rao

Co-Founder & Chief Scientific Officer (CSO)

Our Approach

  • We exploit the fact that metabolomics provides a direct insight into the health-state of an individual.

  • We develop proprietary machine learning tools to de-convolute the complexity of the metabolome and identify Cancer-specific metabolite signatures.

  • By integrating untargeted metabolomics with machine learning data analytics, we generate powerful new approaches for the diagnosis of Cancers even in their early stages of development.

Hey There, We're Hiring

Apply Now

Media Coverage

CSIR Sanctions Project To Develop Human Monoclonal Antibodies As Therapy For COVID-19
Read Article
Indian scientists to develop medicine against COVID-19
Read Article
CSIR approves project to develop human monoclonal antibodies that can...
Read Article
View More Coverage

We Are Here To Support You.

Contact Us

A member of our team will contact you shortly.